These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 28254115)
1. Drug interaction between valproic acid and carbapenems in patients with epileptic seizures. Huang CR; Lin CH; Hsiao SC; Chen NC; Tsai WC; Chen SD; Lu YT; Chuang YC Kaohsiung J Med Sci; 2017 Mar; 33(3):130-136. PubMed ID: 28254115 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological interaction between valproic acid and carbapenem: what about levels in pediatrics? Miranda Herrero MC; Alcaraz Romero AJ; Escudero Vilaplana V; Fernández Lafever SN; Fernández-Llamazares CM; Barredo Valderrama E; Vázquez López M; de Castro P Eur J Paediatr Neurol; 2015 Mar; 19(2):155-61. PubMed ID: 25578527 [TBL] [Abstract][Full Text] [Related]
3. [Seven cases of decreased serum valproic acid concentration during concomitant use of carbapenem antibiotics]. Lee SG; Kim JH; Joo JY; Kwon OH Korean J Lab Med; 2007 Oct; 27(5):338-43. PubMed ID: 18094598 [TBL] [Abstract][Full Text] [Related]
4. Influence of age and co-medication on the steady-state pharmacokinetics of valproic acid in Tunisian patients with epilepsy. Ben Mahmoud L; Hakim A; Ghozzi H; Atheymen R; Sahnoun Z; Zeghal K Rev Neurol (Paris); 2017 Mar; 173(3):159-163. PubMed ID: 28320517 [TBL] [Abstract][Full Text] [Related]
5. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data. Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950 [TBL] [Abstract][Full Text] [Related]
6. First case report of suspected onset of convulsive seizures due to co-administration of valproic acid and tebipenem. Shihyakugari A; Miki A; Nakamoto N; Satoh H; Sawada Y Int J Clin Pharmacol Ther; 2015 Jan; 53(1):92-6. PubMed ID: 25407257 [TBL] [Abstract][Full Text] [Related]
7. Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 cases. Park MK; Lim KS; Kim TE; Han HK; Yi SJ; Shin KH; Cho JY; Shin SG; Jang IJ; Yu KS Ther Drug Monit; 2012 Oct; 34(5):599-603. PubMed ID: 22929406 [TBL] [Abstract][Full Text] [Related]
8. Interactions between carbapenems and valproic acid among the patients in the intensive care units. Chen IL; Lee CH; Hsiao SC; Shih FY J Crit Care; 2021 Apr; 62():151-156. PubMed ID: 33383308 [TBL] [Abstract][Full Text] [Related]
9. Unusual drug reaction between valproate sodium and meropenem. Yoon H; Kim DH Int J Clin Pharm; 2013 Jun; 35(3):316-8. PubMed ID: 23483443 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic interaction on valproic acid and recurrence of epileptic seizures during chemotherapy in an epileptic patient. Ikeda H; Murakami T; Takano M; Usui T; Kihira K Br J Clin Pharmacol; 2005 May; 59(5):593-7. PubMed ID: 15842559 [TBL] [Abstract][Full Text] [Related]
11. Panipenem-betamipron and decreases in serum valproic acid concentration. Yamagata T; Momoi MY; Murai K; Ikematsu K; Suwa K; Sakamoto K; Fujimura A Ther Drug Monit; 1998 Aug; 20(4):396-400. PubMed ID: 9712464 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats. Nakajima Y; Mizobuchi M; Nakamura M; Takagi H; Inagaki H; Kominami G; Koike M; Yamaguchi T Drug Metab Dispos; 2004 Dec; 32(12):1383-91. PubMed ID: 15345660 [TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedication. May TW; Boor R; Rambeck B; Jürgens U; Korn-Merker E; Brandt C Ther Drug Monit; 2011 Apr; 33(2):214-21. PubMed ID: 21383651 [TBL] [Abstract][Full Text] [Related]
14. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage. Mink S; Muroi C; Seule M; Bjeljac M; Keller E Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756 [TBL] [Abstract][Full Text] [Related]
15. The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations. Wu CC; Pai TY; Hsiao FY; Shen LJ; Wu FL Ther Drug Monit; 2016 Oct; 38(5):587-92. PubMed ID: 27322166 [TBL] [Abstract][Full Text] [Related]
16. Correlation of saliva and serum free valproic acid concentrations in persons with epilepsy. Dwivedi R; Gupta YK; Singh M; Joshi R; Tiwari P; Kaleekal T; Tripathi M Seizure; 2015 Feb; 25():187-90. PubMed ID: 25455060 [TBL] [Abstract][Full Text] [Related]
17. Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy. Tseng YL; Huang CR; Lin CH; Lu YT; Lu CH; Chen NC; Chang CC; Chang WN; Chuang YC Medicine (Baltimore); 2014 Sep; 93(11):e66. PubMed ID: 25192484 [TBL] [Abstract][Full Text] [Related]
18. Interaction between valproic acid and carbapenem antibiotics. Mori H; Takahashi K; Mizutani T Drug Metab Rev; 2007; 39(4):647-57. PubMed ID: 18058328 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children. Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762 [TBL] [Abstract][Full Text] [Related]
20. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants. Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]